Skip to main content
Clinical Trials/NCT01368835
NCT01368835
Completed
Not Applicable

Evaluation of the Ulthera™ System For Obtaining Lift and Tightening of the Cheek Tissue and Improvement in Jawline Definition and Submental Skin Laxity

Ulthera, Inc0 sites103 target enrollmentJuly 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mild to Moderate Skin Laxity on Cheek
Sponsor
Ulthera, Inc
Enrollment
103
Primary Endpoint
Change in Overall Lifting and Tightening of Treated Tissue on the Lower Face and Submental Regions.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The clinical trial evaluates the clinical outcomes associated with the non-invasive treatment to obtain lift and tightening of the cheek tissue and improve jawline definition and submental skin laxity utilizing the Ulthera™ System which delivers ultrasound energy in a focused manner below the surface of the skin

Detailed Description

The primary objective of this study is to demonstrate the effectiveness of the Ulthera™ System for the non-invasive dermatological treatment to obtain lift and tighten the cheek tissue. The secondary objective of this study is to demonstrate the effectiveness of the Ulthera™ System for the non-invasive dermatological treatment for improvement in jawline definition and submental skin laxity at 3 and 6 months compared to baseline based on the consensus of the three masked reviewers.

Registry
clinicaltrials.gov
Start Date
July 2010
End Date
April 2011
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female, aged 35 to 60 years
  • Subject in good health
  • Desire lift and tightening of cheek tissue, improvement of jawline definition or submental skin laxity

Exclusion Criteria

  • Pregnant or lactating
  • Has an active systemic or local skin disease that may alter wound healing
  • Severe solar elastosis
  • Excessive subcutaneous fat on the cheeks
  • Excessive skin laxity on the lower face and neck
  • Has significant scarring in areas to be treated
  • Has significant open facial wounds or lesions
  • Has severe or cystic acne on the face

Outcomes

Primary Outcomes

Change in Overall Lifting and Tightening of Treated Tissue on the Lower Face and Submental Regions.

Time Frame: 90D

The percentage of participants assessed to have improvement in skin laxity, i.e., lifted and tightened skin in the areas treated with the Ulthera System, as determined by three masked assessors comparing pre-treatment and 90-days post-treatment photos from 70 subjects who returned for their 90-day follow-up visit.

Secondary Outcomes

  • Change in Submental and Neck Skin Laxity by Quantitative Analysis(90D)
  • Patient Satisfaction Questionnaire(90D)

Similar Trials